Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03935815 · ClinicalTrials.gov registry record · Phase 1
Quadratus Lumborum Nerve Blocks for Myomectomies
A Phase 1 study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT03935815 is a Phase 1 study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 26 participants.
The verdict
NCT03935815, a Phase 1 study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study would like to compare the use of the current standard of care in pain management for patients undergoing laparoscopic myomectomies to the addition of a quadratus lumborum nerve block plus the standard of care. Patients will be consented and the nerve blocks will be placed after the patients are placed under general anesthesia. Standard pain management will continue regardless of which arm of the study patients are in and measurements of pain scores, narcotic usage and abdominal numbness will be assessed in the post-operative period.
Interventions
- DRUG Ropivacaine injection
- PROCEDURE Sham treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2020-06-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03935815
The ClinicalTrials.gov registry entry for NCT03935815 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropivacaine injection is the first listed.
NCT03935815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03935815 about?
NCT03935815 is a clinical study titled "Quadratus Lumborum Nerve Blocks for Myomectomies". This study would like to compare the use of the current standard of care in pain management for patients undergoing laparoscopic myomectomies to the addition of a quadratus lumborum nerve block plus the standard of care. Patients will be consented and the nerve blocks will be placed after the patien...
What is the current status of trial NCT03935815?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2019-05-01. Estimated completion is 2020-06-08.
What interventions are being tested in trial NCT03935815?
The interventions under investigation include: Ropivacaine injection (DRUG), Sham treatment (PROCEDURE).
Who is sponsoring clinical trial NCT03935815?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.